Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19.

ABSTRACT:

SUBMITTER: Zelek WM 

PROVIDER: S-EPMC7605181 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature